Noliprel Bi-Forte (Indapamide, Perindopril Arginine)

Indapamide reduces sodium and water reabsorption in the distal tubules, causing diuresis and decreasing plasma volume. Perindopril arginine blocks the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced aldosterone secretion. Together they lower vascular resistance and blood volume, resulting in a synergistic antihypertensive effect.

The appropriate dose of Noliprel Bi-Forte is determined by the prescribing healthcare professional based on the individual’s clinical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Use of Noliprel Bi-Forte during pregnancy is generally reserved for situations where the benefit outweighs the risk, especially after the first trimester, because ACE inhibitors can affect fetal renal development. Breastfeeding is not recommended without medical guidance, as the drug may pass into milk. Consultation with a healthcare provider is essential.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Noliprel Bi-Forte combines a thiazide‑like diuretic with an ACE inhibitor, offering both diuretic‑induced volume reduction and ACE‑mediated vasodilation. Compared with a common lisinopril/hydrochlorothiazide combo, it provides a similar dual mechanism but uses indapamide, which may have a more favorable metabolic profile and lower risk of certain electrolyte disturbances.

Store the tablets at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Noliprel Bi-Forte is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water; do not crush or chew unless specifically instructed.

The most serious adverse events include angioedema (swelling of the face, lips, tongue, or throat), severe hypotension that can lead to fainting, and acute kidney injury manifested by a rapid rise in serum creatinine. Patients should seek immediate medical attention if any of these symptoms occur.

Noliprel Bi-Forte is contraindicated in patients with a known history of angioedema related to ACE‑inhibitor therapy, severe renal impairment, hyperkalemia, or in the third trimester of pregnancy. It should also be avoided in individuals with hypersensitivity to indapamide, perindopril, or any excipients in the tablet.